Evolent Health (NYSE:EVH) priced $145M of 4.50% convertible senior notes due 2031, offered to qualified institutional buyers under Rule 144A. The deal size was raised from $140M, with an option for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback